Overview

AVODARTĀ® Alopecia Post-marketing Surveillance (PMS)

Status:
Completed
Trial end date:
2012-12-21
Target enrollment:
Participant gender:
Summary
Post-marketing surveillance(PMS) to monitor the safety and effectiveness of dutasteride in Korean androgenetic alopecia patients
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Dutasteride